Back to my company list

BostonGene

The AI engine Fit Assessment

Beta

BostonGene Corporation develops advanced biomedical software that utilizes AI for personalized therapy decision-making in cancer treatment, focusing on individual patient profiles and tumor characteristics. Their solutions include comprehensive molecular and immune profiling to optimize treatment options for patients.

Blurb

BostonGene is a biomedical software company for advanced patient analysis and personalized therapy in the fight against cancer.

HQ Location

United States

Founded

2015

Employees

501 - 1000

Total funding raised

$200.00M

Last Funding Event

Series B, $150.00M, April 6, 2022

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Drug Repurposing

Developer of biomedical software designed for advanced patient analysis and personalized therapy. The company's platform performs analytics for each patient's genetics, tumor, and tumor microenvironment, clinical characteristics, and disease profile, providing clinicians with aid in their evaluation of viable treatment options.